Mee-Young Kang
Papers
1
Total Citations
2
H-Index
1
About
Dr. Mee-Young Kang is a leading hepatobiliary surgeon whose research focuses on optimizing surgical outcomes for hepatocellular carcinoma (HCC), the most common form of liver cancer. Her work centers on defining and improving "textbook outcome"—a composite measure of ideal postoperative recovery—to set new benchmarks in liver surgery. In her landmark 2024 study, she conducted a change point analysis of textbook outcome achievement over two decades at a tertiary referral center, revealing significant evolutionary shifts in surgical practice and patient care. This work, already garnering 2 citations shortly after publication, demonstrates her ability to translate longitudinal clinical data into actionable insights for improving survival and quality of life in HCC patients. Dr. Kang’s contributions are pivotal in advancing precision hepatectomy, reducing complications, and standardizing excellence in liver resection. Her research not only guides surgical decision-making but also provides a framework for assessing institutional performance, making her a key voice in the global effort to elevate outcomes in hepatobiliary oncology.
Research Focus
Key Achievements
Top Papers
- 1